Skip to content

The Study on the Impact of Yiqihuaju Formula on Gut Microbiota in Patients with Abdominal Obesity

The Study on the Impact of Yiqihuaju Formula on Gut Microbiota in Patients with Abdominal Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002327
Enrollment
Unknown
Registered
2025-11-28
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity

Interventions

Treatment group:Yi Qi Hua Ju Fang

Sponsors

Shanghai Putuo District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Subjects have signed the informed consent form. 2. Age between 18 and 70 years old. 3. BMI = 25 kg/m². 4. Male waist circumference = 90 cm, female waist circumference = 85 cm.

Exclusion criteria

Exclusion criteria: 1. Patients with SBP > 160 mmHg or DBP > 100 mmHg; 2. Patients with myocardial infarction, heart failure, or unstable angina; 3. Patients with a history of stroke; 4. Patients with renal insufficiency and serum creatinine > 177 mol/L; 5. Patients with severe liver dysfunction, ALT or AST > 3 times the upper limit of normal; 6. Pregnant or breastfeeding women; 7. Patients with mental illness; 8. Patients with cancer; 9. Patients allergic to the study drug or any of its components; 10. Patients who have received Chinese or Western weight-loss drug therapy within the past three months.

Design outcomes

Primary

MeasureTime frame
Body Mass Index;waist;

Secondary

MeasureTime frame
Appetite Visual Analogue Scale;Gut Microbiota Testing;Metabolomics analysis;

Countries

China

Contacts

Public ContactGu Jiaming

Shanghai Putuo District People's Hospital

2305387@tongji.edu.cn13918327250

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026